Multiple determinants of specific modes of prescription opioid diversion

Journal of Drug Issues

Volumn 41, Issue 2, 2011, Pages 283-304

  Cicero, Theodore J ^a   Kurtz, Steven P ^b   Surratt, Hilary L ^c   Ibanez, Gladys E ^b   Ellis, Matthew S ^b   Levi Minzi, Maria A ^b   Inciardi, James A ^b,c  

^a Washington University   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c Department of Sociology and Criminal Justice and Founding ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052848983     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204261104100207     Document Type: Article

References (50)

1. Aquilino, W. 1994 Interview mode effects in surveys of drug and alcohol use. Public Opinion Quarterly, 54, 362-395.
2. Aquilino, W., & LoSciuto, L. 1990 Effect of interview mode on self-reported drug use. Public Opinion Quarterly, 58, 210-240.
3. Bergman, U., & Dahl-Puustinen, ML. 1989 Use of prescription forgeries in a drug abuse surveillance network. European Journal of Clinical Pharmacology, 36(6), 621-623. (Pubitemid 19175876)
4. Blumenschein, K. 1997 Prescription drug diversion: Fraudulent tactics utilized in the community pharmacy. American Journal of Pharmaceutical Education, 61(2), 184-188.
5. Borsack, S. 1986-87 Hospital drug diversion: The verdict is in. Health Matrix, 4(4), 27-31.
6. Braden, J. B., Russo, J., Fan, M. Y., Edlund, M. J., Martin, B. C., DeVries, A., & Sullivan, M. D. 2010 Emergency department visits among recipients of chronic opioid therapy. Archives of Internal Medicine, 770(16), 1425-1432.
7. Cai, R., Crane, E., Poneleit, K., & Paulozzi, L. 2010 Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004-2008. Journal of Pain and Palliative Care Pharmacotherapy, 24(3), 293-297.
8. CASA (The National Center on Addiction and Substance Abuse at Columbia University) 2004 "You've got drugs!": Prescription drug pushers on the Internet [Online] Retrieved October 31, 2010 from http://www.casacolumbia.org/ Absolutenm/articlefi les/you-ve-got-drugs.pdf.
9. Cicero, T. J., Ellis, M. S., Paradis, A., & Ortbal, Z. 2010 Determinants of fentanyl and other potent μ opioid agonist misuse in opioid-dependent individuals. Pharmacoepidemiology and Drug Safety, 19(1), 1-7.
10. Cicero, T. J., Surratt, H., & Inciardi, J. A. 2007 Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban and urban locations in the United States. Pharmacoepidemiology and Drug Safety, 76(8), 827-840. (Pubitemid 47322580)
11. Cooper, J. R., Czechowicz, D. J., Petersen, R. C, & Molinari, S. P. 1992 Prescription drug diversion control and medical practice. Journal of the American Medical Association, 265(10), 1306-1310.
12. Dart, R. C. 2009 Monitoring risk: Post marketing surveillance and signal detection. Drug and Alcohol Dependence, 105(Suppl 1), S26-S32.
13. Dasgupta, N., & Schnoll, S. H. 2009 Signal detection in post-marketing surveillance for controlled substances. Drug and Alcohol Dependence, 105(Suppl 1), S33-S41.
14. Dennis, M. L., Titus, J. C., White, M. K., Unsicker, J. I., & Hodgkins, D. 2002 Global Appraisal of Individual Needs - Initial (GAIN-I). Bloomington, IL: Chestnut Health Systems.
15. General Accounting Office, U. S. 2003 OxyContin Abuse and Diversion and Efforts to Address the Problem [Report to Congressional Requesters, #GAO-04-110]. Washington, DC: U. S. Government Printing Office.
16. Haase, C. M, & Silbereisen, R. K. 2010 Effects of positive affect on risk perceptions in adolescence and young adulthood. Journal of Adolescence, 34(1), 29-37.
17. Hochstim, J. 1967 A critical comparison of three strategies of collecting data from households. Journal of the American Statistical Association, 62, 976-989.
18. Hollinger, R. C, & Dabney, D. A. 2002 Social factors associated with pharmacists' unauthorized use of mindaltering prescription medications. Journal of Drug Issues, 32(1), 231-264. (Pubitemid 34464912)
19. Inciardi, J. A. 2005 Trends in the Diversion of Prescription Drugs. Paper presented at the 16th Annual Training Conference of the National Association of Drug Diversion Investigators, Myrtle Beach, SC.
20. Inciardi, J. A., & Surratt, H. L. 2005 Researching the Abuse and Diversion of Prescription Drugs. Paper presented at the Abbott Laboratories Symposium on Prescription Drug Abuse, Chicago.
21. Inciardi, J. A., Surratt, H. L., Cicero, T. J., Rosenblum, A., Ahway, C., Bailey, J. E., Dart, R. C, & Burke, J. J. 2010 Prescripton drugs purchased through the Internet: who are the end users? Drug and Alcohol Dependence, 110(1-2), 21-29.
22. Inciardi, J. A., Surratt, H. L., Stivers, Y., & Cicero, T. J. 2009 FDA approvals of generic drugs: Impact on the diversion of opioid analgesics with a potential for abuse. Journal of Opioid Management, 5(2), 81-87.
23. Johanson, C. E., Balster, R. L., Henningfield, J. E., Schuster, C. R., Anthony, J. C., Barthwell, A. G., Coleman, J. J., Dart, R. C., Gorodetzky, C. W., O'Keeffe, C. O., Sellers, E. M., Vocci, F., & Walsh, S. L. 2009 Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: Expert panel report. Drug and Alcohol Dependence, 105(Suppl 1), S33-S41.
24. Leiderman, D. B. 2009 Risk management of drug products and the U. S. Food and Drug Administration: Evolution and context. Drug and Alcohol Dependence, 105(Suppl 1), S9-S13.
25. Manchikanti, L., Fellows, B., Ailinani, H., & Pampati, V. 2010 Therapuetic use, abuse and nonmedical use of opioids: A ten-year perspective. Pain Physician, 13(5), 401-435.
26. McCabe, S. E., Teter, C. J., & Boyd, C. J. 2004 The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use and Misuse, 39(7), 1095-1116. (Pubitemid 39163121)
27. McCormick, C. G. 2006 Regulatory challenges for new formulations of controlled substances in today's environment. Drug and Alcohol Dependence, 83(Suppl 1), S63-S67).
28. Monheit, B. 2010 Prescription drug misuse. Australian Family Physician, 39(8), 540-546.
29. NADDI, National Association of Drug Diversion Investigators 2005a RxPatrol Alert: Delivered Drugs Stolen-Wisconsin. 3-7-2005.
30. NADDI, National Association of Drug Diversion Investigators 2005b RxPatrol Alert: Stolen Prescription Blanks-Texas. 3-2-2005.
31. NADDI, National Association of Drug Diversion Investigators 2005c RxPatrol Alert: Pharmacy Robbery-Florida, North Melbourne. 3-2-2005.
32. NADDI, National Association of Drug Diversion Investigators 2005d RxPatrol Alert: Pharmacy Burglary-Massachusetts, Peabody. 3-2-2005.
33. Okamoto, K., Ohsuka, K., Shiraishi, T., Hukazawa, E., Wakasugi, S., & Furuta, K. 2002 Comparability of epidemiological information between self-and interviewer-administered questionnaires. Journal of Clinical Epidemiology, 55(5), 505-511. (Pubitemid 34462246)
34. Paulozzi, L. J., Logan, J. E., Hall, A. J., McKinstry, E., Kaplan, J. A., & Crosby, A. E. 2009 A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction, 104(9), 1541-1548.
35. Rigg, K. K., March, S. J., & Inciardi, J. A. 2010 Prescription drug abuse & diversion: Role of the pain clinic. Journal of Drug Issues, 40(3), 681-702.
36. Robling, M. R., Ingledew, D. K., Greene, G., Sayers, A., Shaw, C., Sander, L., Russell, I. T., Williams, J. G., & Hood, K. 2010 Applying an extended theoretical framework for data collection mode to health services research. BMC Health Services Research, 10, 180.
37. Ruetsch, C. 2010 Empirical view of opioid dependence. Journal of Managed Care Pharmacy, 616(1 Suppl B), S9-S13.
38. Sale, J. E., Thielke, S., & Topolovec-Vranic, J. 2010 Who is addicted to, and dying from, prescription opioids? Journal of the American Geriatrics Society, 58(7), 1401-1402.
39. Sapienza, F. L. 2006 Abuse deterrent formulations and the Controlled Substances Act (CSA). Drug and Alcohol Dependence, 53(Suppl 1), S23-S30.
40. Simoni-Wastila, L., & Tompkins, C. 2001 Balancing Diversion Control and Medical Necessity: The Case of Prescription Drugs with Abuse Potential. Substance Use and Misuse, 36(9 & 10), 1275-1296.
41. Spiller, H., Bailey, J. E., Dart, R. C., & Spiller, S. S. 2010 Investigation of temporal changes of abuse and misuse of prescription opioids. Journal of Addictive Diseases, 29(1), 78-83.
42. Sproule, B., Brands, B., Li, S., Catz-Biro, L. 2009 Changing patterns in opioid addiction: Characterizing users of oxycodone and other opioids. Canadian Family Physician, 55(1), 68-69, 69.el-5.
43. Strassels, S. A. 2009 Economic Burden of prescription opioid misuse and abuse. Journal of Managed Care Pharmacy, 15(1), 556-562.
44. Tourangeau, R., & Smith, T. W. 1996 Asking sensitive questions: The impact of data collection mode, question format, and question context. Public Opinion Quarterly, 60, 275-304.
45. Trinkoff, A. M., Storr, C. L., & Wall, M. P. 1999 Prescription-type drug misuse and workplace access among nurses. Journal of Addictive Diseases, 18(1), 9-17. (Pubitemid 29231716)
46. Trinkoff, A. M., Zhou, Q., Storr, C. L., & Soeken, K. L. 2000 Workplace access, negative proscriptions, job strain, and substance use in registered nurses. Nursing Research, 49(2), 83-90.
47. Weathermon, R. A. 1999 Controlled substances diversion: Who attempts it and how. U. S. Pharmacist, 24(12), 32-47.
48. Weir, E. 2000 Substance abuse among physicians. Journal of Ayub Medical College, 162(12), 1730. (Pubitemid 30422316)
49. Wilford, B. B., Finch, J., Czechowicz, D. J., & Warren, D. 1994 An overview of prescription drug misuse and abuse: Defining the problem and seeking solutions. The Journal of Law, Medicine & Ethics, 22(3), 197-203.
50. Zacny, J., Bigelow, G., Compton, P., Foley, K., Iguchi, M., & Sannerud, C. 2003 College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug and Alcohol Dependence, 69(3), 215-232. (Pubitemid 36293934)